Swipe om te navigeren naar een ander artikel
Department of Cardiology, Cinere Hospital, Jakarta, Indonesia
Department of Cardiology, Isala Clinics, Zwolle, the Netherlands
J.P. Ottervanger Department of Cardiology, Isala Clinics, PO Box 10500, 8000 GM Zwolle, the Netherlands
Background. Although the beneficial effects of primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) have been demonstrated in a number of trials, most studies were conducted in Western countries. Experience, logistics and patient characteristics may differ in other parts of the world.
Methods. Consecutive patients treated with primary PCI in Cinere Hospital, Jakarta, Indonesia, between January 2008 and October 2008 were compared with those treated in the Isala Clinics, Zwolle, the Netherlands.
Results. During the study period, a total of 596 patients were treated by primary PCI, 568 in Zwolle and 28 in Jakarta. Patients in Indonesia were younger (54 vs 63 years), more often had diabetes (36 vs. 12%) and high lipids and were more often smokers (68 vs. 31%). Time delay between symptom onset and admission was longer in Indonesia. Patients from Indonesia more often had signs of heart failure at admission. The time between admission and balloon inflation was longer in Indonesia. At angiography, patients from Indonesia more often had multivessel disease. There was no difference in the percentage of restoration of TIMI 3 flow by primary PCI between the two hospitals.
Conclusion. Patients with STEMI in Indonesia have a higher risk profile compared with those in the Netherlands, according to prevalence of coronary risk factors, signs of heart failure, multivessel disease and patient delay. Time delay between admission and balloon inflation was much longer in Indonesia, because of both logistic and financial reasons. (Neth Heart J 2009;17:418–21.)
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trial. Lancet. 2003; 361: 13–20.
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999; 341: 625–34.
Zahn R, Schiele R, Schneider S, Gitt AK, Wienbergen H, Seidl K, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? J Am Coll Cardiol. 2001; 37: 1827–35.
Gupta M, Singh N, Verma S. South Asian and cardiovascular risk, what clinicians should know. Circulation. 2006; 113: e924–9.
Santoso T. Prevention of cardiovascular disease in diabetes mellitus: by stressing the CARDS study. Acta Med Indones. 2006; 38: 97–102.
Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, et al; Asia-Pacific Cohort Studies Collaboration. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007; 1: 73–9.
Martiniuk AL, Lee CM, Lam TH, Huxley R, Suh I, Jamrozik K, et al; Asia Pacific Cohort Studies Collaboration. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control. 2006; 15: 181–8.
Woodward M, Lam TH, Barzi F, Patel A, Gu D, Rodgers A, et al; Asia Pacific Cohort Studies Collaboration. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol. 2005; 34: 1036–45.
Boedhi-Darmojo R, Setianto B, Sutedjo, Kusmana D, Andradi, Supari F, et al. A study of baseline risk factors for coronary heart disease: results of population screening in a developing country. Rev Epidemiol Sante Publique. 1990; 38: 487–91.
Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003; 290: 86–97.
Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006; 368: 1681–8.
Pan WH, Yeh WT, Weng LC. Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr. 2008; 17(Suppl 1): 37–42.
Adam FM, Adam JM, Pandeleki N, Mappangara I. Asymptomatic diabetes: the difference between population-based and officebased screening. Acta Med Indones. 2006; 38: 67–71.
Eppens MC, Craig ME, Jones TW, Silink M, Ong S, Ping YJ; The International Diabetes Federation Western Pacific Region Steering Committee. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin. 2006; 22: 1013–20.
De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004; 109: 1223–5.
Jacobs AK, Antman EM, Ellrodt G, Faxon DP, Gregory T, Mensah GA, et al. Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation. 2006; 113: 2152–63.
Stone GW. Angioplasty strategies in ST-segment–elevation myocardial infarction. Part I: primary percutaneous coronary intervention. Circulation. 2008; 118: 538–51.
Hidayat B, Thabrany H, Dong H, Sauerborn R. The effects of mandatory health insurance on equity in access to outpatient care in Indonesia. Health Policy and Planning. 2004; 19: 322–35.
Thabrany H, Gani A, Pujianto, Mayanda L, Mahlil, Budi BS. Center for Health Economic Studies, University of Indonesia, Presented in Social Health Insurance Workshop, WHO SEARO, New Delhi, March 13–15, 2003.
De Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JCA, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol. 1995; 76: 830–3.
- Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison
Y. B. Juwana
J. P. Ottervanger
J-H. E. Dambrink
AW. J. van ’t Hof
A. T. M. Gosselink
J. C. A. Hoorntje
M-J. de Boer
- Bohn Stafleu van Loghum